TIGIT and myeloid sarcoma: Another report showed that activated TIGIT signaling pathway reduces Th1 differentiation included 9 MS patients and 7 healthy controls, indicating that TIGIT stimulation regulates the production of IFN-γ and restores the inhibitory function of Th1 Tregs from patients with MS (18).